Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH), HHS., 19340-19341 [2014-07773]
Download as PDF
<![CDATA[
19340
Federal Register / Vol. 79, No. 67 / Tuesday, April 8, 2014 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK4VPTVN1PROD with NOTICES
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention (CDC)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
Time and Date: 8:30 a.m.–3:00 p.m.
(EST), April 24, 2014.
Place: CDC, Building 21, Rooms 1204
A/B, 1600 Clifton Road NE., Atlanta,
Georgia 30333.
Status: Open to the public, limited
only by the space and phone lines
available. The meeting room
accommodates approximately 50
people. The public is welcome to
participate during the public comment
period, tentatively scheduled from 2:45
p.m. to 2:50 p.m. This meeting is also
available by teleconference. Please dial
(877) 930–8819 and enter code 1579739.
Web links: Connection-1: https://
wm.onlinevideoservice.com/CDC1 Flash
Connection-3 (For Safari and Google
Chrome Users): https://
www.onlinevideoservice.com/clients/
CDC/?mount=CDC3 If you are unable to
connect using the link, copy and paste
the link into your web browser.
Captions are only available on the
Windows Media links (Connections 1).
Viewer’s report is given the next day.
Number for Technical Support: (404)
639–3737.
Purpose: The committee will provide
advice to the CDC Director on strategic
and other broad issues facing CDC.
Matters for Discussion: The Advisory
Committee to the Director will receive
updates from the State, Tribal, Local
and Territorial Subcommittee; the
Health Disparities Subcommittee, the
Global Workgroup, and the Public
Health—Health Care Collaboration
Workgroup; as well as an update from
the CDC Director.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Carmen Villar, MSW, Designated
Federal Officer, ACD, CDC, 1600 Clifton
Road NE., M/S D–14, Atlanta, Georgia
30333. Telephone: (404) 639–7000,
Email: GHickman@cdc.gov. The
deadline for notification of attendance is
April 17, 2014. To register for this
meeting, please send an email to
ACDirector@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
VerDate Mar<15>2010
16:42 Apr 07, 2014
Jkt 232001
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2014–07774 Filed 4–7–14; 8:45 am]
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2014–07775 Filed 4–7–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH), HHS.
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Collaboration on Climate
Sensitive Diseases and Health Effects,
Funding Opportunity Announcement
(FOA) CK14–003, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 1:00 p.m.–3:00 p.m.,
April 22, 2014 (Closed)
Place: Teleconference
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Collaboration on Climate Sensitive
Diseases and Health Effects, FOA CK14–
003’’.
Contact Person for More Information:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road NE., Mailstop E60, Atlanta,
Georgia 30333, Telephone: (404) 718–
8833. The Director, Management
Analysis and Services Office, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), and pursuant to the
requirements of 42 CFR 83.15(a), the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting of the
aforementioned committee:
Time and Date: 8:15 a.m.–5:15 p.m.,
EST, April 29, 2014.
Public Comment Time and Date: 5:15
p.m.–6:15 p.m.*, EST, April 29, 2014.
*Please note that the public comment
period may end before the time
indicated, following the last call for
comments. Members of the public who
wish to provide public comments should
plan to attend the public comment
session at the start time listed.
Place: Augusta Marriott, 2 10th Street,
Augusta, Georgia 30901; Phone: (800)868–5354; Fax: (706) 724–0044. Audio
Conference Call via FTS Conferencing.
The USA toll-free, dial-in number is 1–
866–659–0537 with a pass code of
9933701. Live Meeting Connection:
https://www.livemeeting.com/cc/cdc/
join?id=7CSBK8&role=
attend&pw=ABRWH; Meeting ID:
7CSBK8; Entry Code: ABRWH.
Status: Open to the public, limited
only by the space available. The meeting
space accommodates approximately 150
people.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines
which have been promulgated by the
Department of Health and Human
E:\FR\FM\08APN1.SGM
08APN1
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 67 / Tuesday, April 8, 2014 / Notices
Services (HHS) as a final rule, advice on
methods of dose reconstruction which
have also been promulgated by HHS as
a final rule, advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program, and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to the CDC.
NIOSH implements this responsibility
for CDC. The charter was issued on
August 3, 2001, renewed at appropriate
intervals, and will expire on August 3,
2015.
Purpose: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters for Discussion: The agenda for
the Advisory Board meeting includes:
NIOSH Program Update; Department of
Labor Program Update; Department of
Energy Program Update; SEC petitions
for: Nuclear Metal Inc. (West Concord,
MA), Joslyn Manufacturing and Supply
Company (Fort Wayne, IN) and
Savannah River Site (Aiken, SC); SEC
Issues Work Group Report on
‘‘Sufficient Accuracy’’/Co-Worker Dose
Modeling; SEC Petitions Update; and
Board Work Session.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot
attend, written comments may be
submitted in accordance with the
redaction policy provided below. Any
written comments received will be
provided at the meeting and should be
submitted to the contact person below
well in advance of the meeting.
Policy on Redaction of Board Meeting
Transcripts (Public Comment): (1) If a
person making a comment gives his or
her personal information, no attempt
will be made to redact the name;
however, NIOSH will redact other
personally identifiable information,
such as contact information, social
VerDate Mar<15>2010
16:42 Apr 07, 2014
Jkt 232001
security numbers, case numbers, etc., of
the commenter.
(2) If an individual in making a
statement reveals personal information
(e.g., medical or employment
information) about themselves that
information will not usually be
redacted. The NIOSH Freedom of
Information Act (FOIA) coordinator
will, however, review such revelations
in accordance with the Federal
Advisory Committee Act and if deemed
appropriate, will redact such
information.
(3) If a commenter reveals personal
information concerning a living third
party, that information will be reviewed
by the NIOSH FOIA coordinator, and
upon determination, if deemed
appropriated, such information will be
redacted, unless the disclosure is made
by the third party’s authorized
representative under the Energy
Employees Occupational Illness
Compensation Program Act (EEOICPA)
program.
(4) In general, information concerning
a deceased third party may be disclosed;
however, such information will be
redacted if (a) the disclosure is made by
an individual other than the survivor
claimant, a parent, spouse, or child, or
the authorized representative of the
deceased third party; (b) if it is unclear
whether the third party is living or
deceased; or (c) the information is
unrelated or irrelevant to the purpose of
the disclosure.
The Board will take reasonable steps
to ensure that individuals making
public comment are aware of the fact
that their comments (including their
name, if provided) will appear in a
transcript of the meeting posted on a
public Web site. Such reasonable steps
include: (a) A statement read at the start
of each public comment period stating
that transcripts will be posted and
names of speakers will not be redacted;
(b) A printed copy of the statement
mentioned in (a) above will be
displayed on the table where
individuals sign up to make public
comments; (c) A statement such as
outlined in (a) above will also appear
with the agenda for a Board Meeting
when it is posted on the NIOSH Web
site; (d) A statement such as in (a) above
will appear in the Federal Register
Notice that announces Board and
Subcommittee meetings.
Contact Person For More Information:
Theodore Katz, M.P.A., Designated
Federal Officer, NIOSH, CDC, 1600
Clifton Road NE., MS E–20, Atlanta GA
30333, Telephone: (513) 533–6800, Toll
Free: 1–800–CDC–INFO, Email: dcas@
cdc.gov
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
19341
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2014–07773 Filed 4–7–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
Privacy Act of 1974, Report of New
System of Records
Department of Health and
Human Services (HHS), Centers for
Medicare & Medicaid Services (CMS).
ACTION: Notice of a New System of
Records (SOR).
AGENCY:
In accordance with the
requirements of the Privacy Act of 1974,
CMS is establishing a new SOR titled,
‘‘Hospice Item Set (HIS) System,’’
System No. 09–70–0548. The new
system will support the collection of
data required for the Hospice Quality
Reporting Program (HQRP) pursuant to
Section 3004(c) of the Patient Protection
and Affordable Care Act of 2010 (ACA)
(Pub. L. 111–148), which amended the
Social Security Act (the Act) (42 U.S.C.
1814(i)). HIS is a standardized, patientlevel data collection vehicle consisting
of data elements confirming that the
appropriate assessments were made and
inquiries or concerns were addressed for
each patient at the time of admission for
the following domains of care: (1) Pain;
(2) Respiratory Status; (3) Medications;
(4) Patient Preferences; and (5) Beliefs &
Values.
DATES: Effective Dates: Effective 30 days
after publication. Written comments
should be submitted on or before the
effective date. HHS/CMS/CCSQ may
publish an amended SORN in light of
any comments received.
ADDRESSES: The public should address
comments to: CMS Privacy Officer,
Privacy Policy Compliance Group,
Office of E-Health Standards & Services,
Office of Enterprise Management,
Centers for Medicare & Medicaid
Services, 7500 Security Boulevard,
Baltimore, MD 21244–1870, Mailstop:
S2–24–25, Office: (410) 786–5357,
SUMMARY:
E:\FR\FM\08APN1.SGM
08APN1
]]>Agencies
[Federal Register Volume 79, Number 67 (Tuesday, April 8, 2014)]
[Notices]
[Pages 19340-19341]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-07773]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or Advisory
Board), National Institute for Occupational Safety and Health (NIOSH),
HHS.
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42
CFR 83.15(a), the Centers for Disease Control and Prevention (CDC),
announces the following meeting of the aforementioned committee:
Time and Date: 8:15 a.m.-5:15 p.m., EST, April 29, 2014.
Public Comment Time and Date: 5:15 p.m.-6:15 p.m.*, EST, April 29,
2014.
*Please note that the public comment period may end before the time
indicated, following the last call for comments. Members of the public
who wish to provide public comments should plan to attend the public
comment session at the start time listed.
Place: Augusta Marriott, 2 10th Street, Augusta, Georgia 30901;
Phone: (800)-868-5354; Fax: (706) 724-0044. Audio Conference Call via
FTS Conferencing. The USA toll-free, dial-in number is 1-866-659-0537
with a pass code of 9933701. Live Meeting Connection: https://www.livemeeting.com/cc/cdc/join?id=7CSBK8&role=attend&pw=ABRWH; Meeting
ID: 7CSBK8; Entry Code: ABRWH.
Status: Open to the public, limited only by the space available.
The meeting space accommodates approximately 150 people.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines which have
been promulgated by the Department of Health and Human
[[Page 19341]]
Services (HHS) as a final rule, advice on methods of dose
reconstruction which have also been promulgated by HHS as a final rule,
advice on the scientific validity and quality of dose estimation and
reconstruction efforts being performed for purposes of the compensation
program, and advice on petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and will expire on August 3, 2015.
Purpose: This Advisory Board is charged with (a) providing advice
to the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advise the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class.
Matters for Discussion: The agenda for the Advisory Board meeting
includes: NIOSH Program Update; Department of Labor Program Update;
Department of Energy Program Update; SEC petitions for: Nuclear Metal
Inc. (West Concord, MA), Joslyn Manufacturing and Supply Company (Fort
Wayne, IN) and Savannah River Site (Aiken, SC); SEC Issues Work Group
Report on ``Sufficient Accuracy''/Co-Worker Dose Modeling; SEC
Petitions Update; and Board Work Session.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may be
submitted in accordance with the redaction policy provided below. Any
written comments received will be provided at the meeting and should be
submitted to the contact person below well in advance of the meeting.
Policy on Redaction of Board Meeting Transcripts (Public Comment):
(1) If a person making a comment gives his or her personal information,
no attempt will be made to redact the name; however, NIOSH will redact
other personally identifiable information, such as contact information,
social security numbers, case numbers, etc., of the commenter.
(2) If an individual in making a statement reveals personal
information (e.g., medical or employment information) about themselves
that information will not usually be redacted. The NIOSH Freedom of
Information Act (FOIA) coordinator will, however, review such
revelations in accordance with the Federal Advisory Committee Act and
if deemed appropriate, will redact such information.
(3) If a commenter reveals personal information concerning a living
third party, that information will be reviewed by the NIOSH FOIA
coordinator, and upon determination, if deemed appropriated, such
information will be redacted, unless the disclosure is made by the
third party's authorized representative under the Energy Employees
Occupational Illness Compensation Program Act (EEOICPA) program.
(4) In general, information concerning a deceased third party may
be disclosed; however, such information will be redacted if (a) the
disclosure is made by an individual other than the survivor claimant, a
parent, spouse, or child, or the authorized representative of the
deceased third party; (b) if it is unclear whether the third party is
living or deceased; or (c) the information is unrelated or irrelevant
to the purpose of the disclosure.
The Board will take reasonable steps to ensure that individuals
making public comment are aware of the fact that their comments
(including their name, if provided) will appear in a transcript of the
meeting posted on a public Web site. Such reasonable steps include: (a)
A statement read at the start of each public comment period stating
that transcripts will be posted and names of speakers will not be
redacted; (b) A printed copy of the statement mentioned in (a) above
will be displayed on the table where individuals sign up to make public
comments; (c) A statement such as outlined in (a) above will also
appear with the agenda for a Board Meeting when it is posted on the
NIOSH Web site; (d) A statement such as in (a) above will appear in the
Federal Register Notice that announces Board and Subcommittee meetings.
Contact Person For More Information: Theodore Katz, M.P.A.,
Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road NE., MS E-20,
Atlanta GA 30333, Telephone: (513) 533-6800, Toll Free: 1-800-CDC-INFO,
Email: dcas@cdc.gov
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2014-07773 Filed 4-7-14; 8:45 am]
BILLING CODE 4163-18-P
